Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
Sponsor
University of Nebraska (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00672672
Collaborator
(none)
0
1
1
12
0
Study Details
Study Description
Brief Summary
The purpose of this study is to determine if the use of autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease the incidence of infection in patients undergoing coronary artery bypass grafting surgery
Study Design
Study Type:
Interventional
Actual Enrollment
:
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
Actual Study Start Date
:
Jan 1, 2009
Actual Primary Completion Date
:
Jan 1, 2010
Actual Study Completion Date
:
Jan 1, 2010
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: II Patients who do not receive platlet gel. |
Biological: autologous platelet gel
Patients will receive APG to the surgical site in the operating room. The control site will receive no treatment.
|
Outcome Measures
Primary Outcome Measures
- The surgical sites will be assessed for degree of healing and signs and symptoms of infection on postop days one and three and during the patients' follow up visits in the clinic. [30 days]
Eligibility Criteria
Criteria
Ages Eligible for Study:
19 Years
to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Any patient who meets criteria and consents to undergo a CABG procedure involving conduit sites and consents to this study.
Exclusion Criteria:
- Any patient, after inclusion, whom is later determined to have had on-going therapy that could influence wound healing such as radiation or chemotherapy, extensive steroid use, or accidental trauma such as burns, etc.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of Nebraska Medical Center | Omaha | Nebraska | United States | 68198 |
Sponsors and Collaborators
- University of Nebraska
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University of Nebraska
ClinicalTrials.gov Identifier:
NCT00672672
Other Study ID Numbers:
- 065-08
First Posted:
May 6, 2008
Last Update Posted:
Apr 11, 2018
Last Verified:
Apr 1, 2018
Keywords provided by University of Nebraska
Additional relevant MeSH terms: